PinkDx
PrivateLast Round
Series A
Extension
Jan 23, 2025
Total Funding Raised
$50M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
PinkDx is a biotechnology company that develops non-invasive molecular diagnostic tests for the early detection of gynecological cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Medical Devices
Business Model
B2B
Customer Profile
Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PinkDx Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
PinkDx Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Jan 23, 2025 | ||||
| Series A | Apr 25, 2024 |
Key People
Founding team and executive leadership
PinkDx Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The Production Board | Series A Extension, Series A |
| BEVC | Series A, Series A Extension |
| Catalio Capital Management | Series A, Series A Extension |
| Byers Capital | Series A Extension, Series A |
| Mountain Group Partners | Series A, Series A Extension |
| Blue Venture Fund | Series A, Series A Extension |
| Sandbox Industries | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 16, 2026
Monthly visitors grew 100% MoM, reaching 2.2K.
- Apr 16, 2026
Grew 19% QoQ, from 31 to 37 employees.
PinkDx Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about PinkDx's valuation, stock price, and market status.